FDA OKs Diabetes Drug for Type 2 Heart Failure Risk

The FDA granted a new use for diabetes drug Farxiga (dapagliflozin): to reduce the risk of hospitalization for heart failure in adults who have type 2 diabetes and established heart disease or risk factors for it.
Source: WebMD Health - Category: Consumer Health News Source Type: news